Adeno-associated virus type 2 infection of nude mouse human breast cancer xenograft induces necrotic death and inhibits tumor growth

References

• DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011; 61:409 - 18; http://dx.doi.org/10.3322/caac.20134; PMID: 21969133
   PubMed Web of Science ®Google Scholar
• Chalasani P, Downey L, Stopeck AT. Caring for the breast cancer survivor: a guide for primary care physicians. Am J Med 2010; 123:489 - 95; http://dx.doi.org/10.1016/j.amjmed.2009.09.042; PMID: 20569749
   PubMed Web of Science ®Google Scholar
• Hamilton A, Hortobagyi G. Chemotherapy: what progress in the last 5 years?. J Clin Oncol 2005; 23:1760 - 75; http://dx.doi.org/10.1200/JCO.2005.10.034; PMID: 15755984
   PubMed Web of Science ®Google Scholar
• Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 1998; 90:814 - 23; http://dx.doi.org/10.1093/jnci/90.11.814; PMID: 9625169
   PubMed Web of Science ®Google Scholar
• Pegram MD, Pietras R, Bajamonde A, Klein P, Fyfe G. Targeted therapy: wave of the future. J Clin Oncol 2005; 23:1776 - 81; http://dx.doi.org/10.1200/JCO.2005.11.029; PMID: 15755985
   PubMed Web of Science ®Google Scholar
• Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 2001; 276:9817 - 24; http://dx.doi.org/10.1074/jbc.M010840200; PMID: 11139588
   PubMed Web of Science ®Google Scholar
• Simstein R, Burow M, Parker A, Weldon C, Beckman B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood) 2003; 228:995 - 1003; PMID: 14530507
   PubMed Web of Science ®Google Scholar
• Rahman KM, Sarkar FH. Steroid hormone mimics: molecular mechanisms of cell growth and apoptosis in normal and malignant mammary epithelial cells. J Steroid Biochem Mol Biol 2002; 80:191 - 201; http://dx.doi.org/10.1016/S0960-0760(01)00186-8; PMID: 11897503
   PubMed Web of Science ®Google Scholar
• Lewis JS, Cheng D, Jordan VC. Targeting oestrogen to kill the cancer but not the patient. Br J Cancer 2004; 90:944 - 9; http://dx.doi.org/10.1038/sj.bjc.6601627; PMID: 14997187
   PubMed Web of Science ®Google Scholar
• Gelber RD, Bonetti M, Cole BF, Gelber S, Goldhirsch A. Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group. Recent Results Cancer Res 1998; 152:373 - 89; http://dx.doi.org/10.1007/978-3-642-45769-2_36; PMID: 9928573
   PubMedGoogle Scholar
• Minami CA, Chung DU, Chang HR. Management options in triple-negative breast cancer. Breast Cancer (Auckl) 2011; 5:175 - 99; PMID: 21863131
   PubMedGoogle Scholar
• Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747 - 52; http://dx.doi.org/10.1038/35021093; PMID: 10963602
   PubMed Web of Science ®Google Scholar
• Ahmad N, Kumar R. Steroid hormone receptors in cancer development: a target for cancer therapeutics. Cancer Lett 2011; 300:1 - 9; http://dx.doi.org/10.1016/j.canlet.2010.09.008; PMID: 20926181
   PubMed Web of Science ®Google Scholar
• Orlando L, Schiavone P, Fedele P, Calvani N, Nacci A, Rizzo P, Marino A, D’Amico M, Sponziello F, Mazzoni E, et al. Molecularly targeted endocrine therapies for breast cancer. Cancer Treat Rev 2010; 36:Suppl 3 S67 - 71; http://dx.doi.org/10.1016/S0305-7372(10)70023-2; PMID: 21129614
   PubMed Web of Science ®Google Scholar
• Hudis CA, Gianni L. Triple-negative breast cancer: an unmet medical need. Oncologist 2011; 16:Suppl 1 1 - 11; http://dx.doi.org/10.1634/theoncologist.2011-S1-01; PMID: 21278435
   PubMed Web of Science ®Google Scholar
• Alam S, Bowser BS, Conway MJ, Israr M, Tandon A, Meyers C. Adeno-associated virus type 2 infection activates caspase dependent and independent apoptosis in multiple breast cancer lines but not in normal mammary epithelial cells. Mol Cancer 2011; 10:97; http://dx.doi.org/10.1186/1476-4598-10-97; PMID: 21827643
   PubMed Web of Science ®Google Scholar
• Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000; 16:653 - 99; http://dx.doi.org/10.1146/annurev.cellbio.16.1.653; PMID: 11031250
   PubMed Web of Science ®Google Scholar
• Matsumura I, Tanaka H, Kanakura Y. E2F1 and c-Myc in cell growth and death. Cell Cycle 2003; 2:333 - 8; http://dx.doi.org/10.4161/cc.2.4.428; PMID: 12851485
   PubMed Web of Science ®Google Scholar
• Iatropoulos MJ, Williams GM. Proliferation markers. Exp Toxicol Pathol 1996; 48:175 - 81; http://dx.doi.org/10.1016/S0940-2993(96)80039-X; PMID: 8672872
   PubMed Web of Science ®Google Scholar
• Yu CC, Woods AL, Levison DA. The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J 1992; 24:121 - 31; http://dx.doi.org/10.1007/BF01047461; PMID: 1349881
   PubMedGoogle Scholar
• Alam S, Meyers C. Adeno-associated virus type 2 induces apoptosis in human papillomavirus-infected cell lines but not in normal keratinocytes. J Virol 2009; 83:10286 - 92; http://dx.doi.org/10.1128/JVI.00343-09; PMID: 19625406
   PubMed Web of Science ®Google Scholar
• Seraj MJ, Samant RS, Verderame MF, Welch DR. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 2000; 60:2764 - 9; PMID: 10850410
   PubMed Web of Science ®Google Scholar
• Girgert R, Emons G, Gründker C. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy. Breast Cancer Res Treat 2012; 134:199 - 205; http://dx.doi.org/10.1007/s10549-012-1968-x; PMID: 22290080
   PubMed Web of Science ®Google Scholar
• Alam S, Sen E, Brashear H, Meyers C. Adeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma line. J Virol 2006; 80:4927 - 39; http://dx.doi.org/10.1128/JVI.80.10.4927-4939.2006; PMID: 16641284
   PubMed Web of Science ®Google Scholar
• Kim YG, Bi W, Feliciano ES, Drake RR, Stambrook PJ. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene. Cancer Gene Ther 2000; 7:240 - 6; http://dx.doi.org/10.1038/sj.cgt.7700113; PMID: 10770632
   PubMed Web of Science ®Google Scholar
• Trepel M, Stoneham CA, Eleftherohorinou H, Mazarakis ND, Pasqualini R, Arap W, Hajitou A. A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer. Mol Cancer Ther 2009; 8:2383 - 91; http://dx.doi.org/10.1158/1535-7163.MCT-09-0110; PMID: 19671758
   PubMed Web of Science ®Google Scholar
• Berns KI, Giraud C. Biology of adeno-associated virus. Curr Top Microbiol Immunol 1996; 218:1 - 23; http://dx.doi.org/10.1007/978-3-642-80207-2_1; PMID: 8794242
   PubMed Web of Science ®Google Scholar
• Leonard CJ, Berns KI. Cloning, expression, and partial purification of Rep78: an adeno-associated virus replication protein. Virology 1994; 200:566 - 73; http://dx.doi.org/10.1006/viro.1994.1219; PMID: 8178443
   PubMed Web of Science ®Google Scholar
• Nash K, Chen W, Salganik M, Muzyczka N. Identification of cellular proteins that interact with the adeno-associated virus rep protein. J Virol 2009; 83:454 - 69; http://dx.doi.org/10.1128/JVI.01939-08; PMID: 18971280
   PubMed Web of Science ®Google Scholar
• Duprez L, Wirawan E, Vanden Berghe T, Vandenabeele P. Major cell death pathways at a glance. Microbes Infect 2009; 11:1050 - 62; http://dx.doi.org/10.1016/j.micinf.2009.08.013; PMID: 19733681
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281:1309 - 12; http://dx.doi.org/10.1126/science.281.5381.1309; PMID: 9721092
   PubMed Web of Science ®Google Scholar
• Lan L, Gorke S, Rau SJ, Zeisel MB, Hildt E, Himmelsbach K, Carvajal-Yepes M, Huber R, Wakita T, Schmitt-Graeff A, et al. Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J Immunol 2008; 181:4926 - 35; http://dx.doi.org/10.4049/jimmunol.181.7.4926; PMID: 18802096
   PubMed Web of Science ®Google Scholar
• Bröker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 2005; 11:3155 - 62; http://dx.doi.org/10.1158/1078-0432.CCR-04-2223; PMID: 15867207
   PubMed Web of Science ®Google Scholar
• Agarwal A, Mahfouz RZ, Sharma RK, Sarkar O, Mangrola D, Mathur PP. Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes. Reprod Biol Endocrinol 2009; 7:143; http://dx.doi.org/10.1186/1477-7827-7-143; PMID: 19961617
   PubMed Web of Science ®Google Scholar
• Althaus FR, Kleczkowska HE, Malanga M, Müntener CR, Pleschke JM, Ebner M, Auer B. Poly ADP-ribosylation: a DNA break signal mechanism. Mol Cell Biochem 1999; 193:5 - 11; http://dx.doi.org/10.1023/A:1006975002262; PMID: 10331631
   PubMed Web of Science ®Google Scholar
• Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297:259 - 63; http://dx.doi.org/10.1126/science.1072221; PMID: 12114629
   PubMed Web of Science ®Google Scholar
• Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A 1999; 96:13978 - 82; http://dx.doi.org/10.1073/pnas.96.24.13978; PMID: 10570184
   PubMed Web of Science ®Google Scholar
• Szabó C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998; 19:287 - 98; http://dx.doi.org/10.1016/S0165-6147(98)01193-6; PMID: 9703762
   PubMed Web of Science ®Google Scholar
• Alano CC, Ying W, Swanson RA. Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J Biol Chem 2004; 279:18895 - 902; http://dx.doi.org/10.1074/jbc.M313329200; PMID: 14960594
   PubMed Web of Science ®Google Scholar
• Delavallée L, Cabon L, Galán-Malo P, Lorenzo HK, Susin SA. AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life 2011; 63:221 - 32; http://dx.doi.org/10.1002/iub.432; PMID: 21438113
   PubMed Web of Science ®Google Scholar
• Neganova I, Lako M. G1 to S phase cell cycle transition in somatic and embryonic stem cells. J Anat 2008; 213:30 - 44; http://dx.doi.org/10.1111/j.1469-7580.2008.00931.x; PMID: 18638068
   PubMed Web of Science ®Google Scholar
• Kuntz K, O’Connell MJ. The G(2) DNA damage checkpoint: could this ancient regulator be the Achilles heel of cancer?. Cancer Biol Ther 2009; 8:1433 - 9; http://dx.doi.org/10.4161/cbt.8.15.9081; PMID: 19574738
   PubMed Web of Science ®Google Scholar
• Hoffman B, Liebermann DA. Apoptotic signaling by c-MYC. Oncogene 2008; 27:6462 - 72; http://dx.doi.org/10.1038/onc.2008.312; PMID: 18955973
   PubMed Web of Science ®Google Scholar
• Guerra L, Albihn A, Tronnersjö S, Yan Q, Guidi R, Stenerlöw B, Sterzenbach T, Josenhans C, Fox JG, Schauer DB, et al. Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage. PLoS One 2010; 5:e8924; http://dx.doi.org/10.1371/journal.pone.0008924; PMID: 20111719
   PubMedGoogle Scholar
• Berthet C, Raj K, Saudan P, Beard P. How adeno-associated virus Rep78 protein arrests cells completely in S phase. Proc Natl Acad Sci U S A 2005; 102:13634 - 9; http://dx.doi.org/10.1073/pnas.0504583102; PMID: 16157891
   PubMed Web of Science ®Google Scholar
• Cozzi P. The discovery of a new potential anticancer drug: a case history. Farmaco 2003; 58:213 - 20; http://dx.doi.org/10.1016/S0014-827X(03)00014-4; PMID: 12620417
   PubMedGoogle Scholar
• Monteiro R, Calhau C, Silva AO, Pinheiro-Silva S, Guerreiro S, Gärtner F, Azevedo I, Soares R. Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. J Cell Biochem 2008; 104:1699 - 707; http://dx.doi.org/10.1002/jcb.21738; PMID: 18348194
   PubMed Web of Science ®Google Scholar
• Bingle L, Lewis CE, Corke KP, Reed MW, Brown NJ. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 2006; 94:101 - 7; http://dx.doi.org/10.1038/sj.bjc.6602901; PMID: 16404363
   PubMed Web of Science ®Google Scholar
• Zheng J, Koblinski JE, Dutson LV, Feeney YB, Clevenger CV. Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. Cancer Res 2008; 68:7769 - 78; http://dx.doi.org/10.1158/0008-5472.CAN-08-0639; PMID: 18829531
   PubMed Web of Science ®Google Scholar
• Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Breast Cancer Res 2005; 7:R422 - 35; http://dx.doi.org/10.1186/bcr1019; PMID: 15987447
   PubMed Web of Science ®Google Scholar
• Yagata H, Kajiura Y, Yamauchi H. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy. Breast Cancer 2011; 18:165 - 73; http://dx.doi.org/10.1007/s12282-011-0254-9; PMID: 21290263
   PubMed Web of Science ®Google Scholar
• Manson JE. The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy. Metabolism 2013; 62:Suppl 1 S15 - 9; PMID: 23018143
   PubMedGoogle Scholar
• Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et al, METABRIC Group. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012; 486:346 - 52; PMID: 22522925
   PubMed Web of Science ®Google Scholar
• Shevde LA, Samant RS, Paik JC, Metge BJ, Chambers AF, Casey G, Frost AR, Welch DR. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clin Exp Metastasis 2006; 23:123 - 33; http://dx.doi.org/10.1007/s10585-006-9013-2; PMID: 16830223
   PubMed Web of Science ®Google Scholar
• Ashwell S, Zabludoff S. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy. Clin Cancer Res 2008; 14:4032 - 7; http://dx.doi.org/10.1158/1078-0432.CCR-07-5138; PMID: 18593978
   PubMed Web of Science ®Google Scholar
• Raj K, Ogston P, Beard P. Virus-mediated killing of cells that lack p53 activity. Nature 2001; 412:914 - 7; http://dx.doi.org/10.1038/35091082; PMID: 11528480
   PubMed Web of Science ®Google Scholar
• Elliott MJ, Dong YB, Yang H, McMasters KM. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells. Clin Cancer Res 2001; 7:3590 - 7; PMID: 11705881
   PubMed Web of Science ®Google Scholar
• Lüscher B, Larsson LG. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene 1999; 18:2955 - 66; http://dx.doi.org/10.1038/sj.onc.1202750; PMID: 10378692
   PubMed Web of Science ®Google Scholar
• Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 1992; 359:423 - 6; http://dx.doi.org/10.1038/359423a0; PMID: 1406955
   PubMed Web of Science ®Google Scholar
• Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 2007; 10:13 - 29; http://dx.doi.org/10.1016/j.drup.2007.01.003; PMID: 17303468
   PubMed Web of Science ®Google Scholar
• Lavrik IN, Krammer PH. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ 2012; 19:36 - 41; http://dx.doi.org/10.1038/cdd.2011.155; PMID: 22075988
   PubMed Web of Science ®Google Scholar
• Ozbun MA, Meyers C. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology 1998; 248:218 - 30; http://dx.doi.org/10.1006/viro.1998.9285; PMID: 9721231
   PubMed Web of Science ®Google Scholar
• Song C, Appleyard V, Murray K, Frank T, Sibbett W, Cuschieri A, Thompson A. Thermographic assessment of tumor growth in mouse xenografts. Int J Cancer 2007; 121:1055 - 8; http://dx.doi.org/10.1002/ijc.22808; PMID: 17487841
   PubMed Web of Science ®Google Scholar
• Alam S, Conway MJ, Chen HS, Meyers C. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol 2008; 82:1053 - 8; http://dx.doi.org/10.1128/JVI.01813-07; PMID: 17989183
   PubMed Web of Science ®Google Scholar
• Meyers C, Frattini MG, Hudson JB, Laimins LA. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992; 257:971 - 3; http://dx.doi.org/10.1126/science.1323879; PMID: 1323879
   PubMed Web of Science ®Google Scholar
• Ozbun MA, Meyers C. Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes. J Virol 1996; 70:5437 - 46; PMID: 8764055
   PubMed Web of Science ®Google Scholar
• Alam S, Bowser BS, Conway MJ, Israr M, Ryndock EJ, Xi LF, Meyers C. Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene. J Virol 2010; 84:4630 - 45; http://dx.doi.org/10.1128/JVI.02431-09; PMID: 20181698
   PubMed Web of Science ®Google Scholar